Skip to main content

Web Exclusives

Gastrointestinal Cancers

Second-Line Pembrolizumab Therapy Conveys Survival Benefit in Patients with Advanced Esophageal Cancer

Gastrointestinal Cancers

ASCO Clinical Practice Guidelines for Clinician Management of Patients with Advanced Esophageal Cancer

Gastrointestinal Cancers

CheckMate 648 Study Data Indicate Improved Overall Survival for Patients with Advanced Esophageal Squamous-Cell Carcinoma Treated with Nivolumab and Ipilimumab or Chemotherapy

Gastrointestinal Cancers

Immune Checkpoint Analysis in Gastric Adenocarcinoma

Gastrointestinal Cancers

Second-Line Trastuzumab Deruxtecan in Patients with Metastatic Gastric or Esophageal Junction Cancer Demonstrates Clinical Efficacy

Meeting Highlights

Multiple Myeloma, ASCO Highlights

New CAR T-Cell Therapy Produces Durable Responses in Relapsed or Refractory Multiple Myeloma

Wayne Kuznar

FDA Updates

Pylarify Second Radioactive Imaging Drug FDA Approved for PSMA-Positive Prostate Cancer

Meeting Highlights

Biosimilars, ASCO Highlights

Rapid Biosimilar Adoption Possible in Community Oncology Practice

Chase Doyle

Meeting Highlights

Lung Cancer, ASCO Highlights

Atezolizumab Extends Disease-Free Survival in PD-L1−Positive Early-Stage NSCLC

Phoebe Starr

Meeting Highlights

Prostate Cancer, ASCO Highlights

¹⁷⁷Lu-PSMA-617 Prolongs Survival in Patients with Metastatic Castration-Resistant Prostate Cancer

Phoebe Starr

Page 5 of 43
Results 41 - 50 of 428